CuraGen Corporation to Present at the 19th Annual Piper Jaffray Health Care Conference

BRANFORD, Conn., Nov. 26 /PRNewswire-FirstCall/ -- CuraGen Corporation , a clinical-stage biopharmaceutical company focused on oncology, announced today that Dr. Timothy M. Shannon, President and Chief Executive Officer, will present a corporate update at the 19th Annual Piper Jaffray Health Care Conference on Wednesday, November 28, 2007, at 3:00 p.m. Eastern time. The conference is being held at The Pierre Hotel in New York, NY.

Access to a live webcast of the presentation will be available from the Investor Relations section of CuraGen's website at http://www.curagen.com. A replay of the webcast will be available after the presentation and archived for 30 days thereafter.

About CuraGen

CuraGen Corporation is a dedicated clinical-stage biopharmaceutical company developing diverse approaches for the treatment of cancer including the histone deacetylase inhibitor, belinostat, and the antibody-drug conjugate, CR011-vcMMAE. By leveraging drug development strengths cultivated over the years, CuraGen expects to make a difference by advancing its promising therapeutics to address the unmet medical needs of cancer patients. CuraGen Corporation is headquartered in Branford, Connecticut. For additional information please visit www.curagen.com.

gschulman@curagen.com

CONTACT: Glenn Schulman, Pharm.D., Director of Investor Relations,
gschulman@curagen.com, +1-888-436-6642

Web site: http://www.curagen.com/

Back to news